Read + Share
Hu S, Gu S, Qi C, Wang S, et al. Cost-Utility Analysis of Semaglutide for type 2 diabetes after its Addition to
the National Medical Insurance System in China. Diabetes Obes Metab 2022 Oct 4. doi: 10.1111/dom.14881.
PMID: 36193880
|
 |
|
Hu S, Gu S, Qi C, Wang S, et al. Cost-Utility Analysis of Semaglutide for type 2 diabetes after its Addition to
the National Medical Insurance System in China. Diabetes Obes Metab 2022 Oct 4. doi: 10.1111/dom.14881.
PMID: 36193880
|
|
|
|